Table 3. Details of the MNC counts, Viability and CD34+ cells per million in each patient at the time of injection

Publisher： Nova Science Publishers, Inc.

ISSN： 1556-8539

Source： Journal of Stem Cells, Vol., Iss., 2016-01, pp. : 47-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Table 5. The number of CD 34% cells infused to each patient the viability ranged from 90 to 94%

By  

Journal of Stem Cells, Vol. , Iss. , 2016-01 ,pp. : 61-61

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Table 1. Increase in the level of hematopoietic progenitor cells CD34+ in peripheral blood following seven transfusions to a 60-year-old patient of mononuclear fraction of peripheral blood from a 20-year-old donor [6]

By  

Journal of Stem Cells, Vol. , Iss. , 2016-04 ,pp. : 50-49

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Table 3. Relative expression folds change between CD34 and mononuclear cells of HIF1α, STPK, ALDH and IDH. Data were expressed as mean ± S.D

By  

Journal of Stem Cells, Vol. , Iss. , 2016-07 ,pp. : 24-24

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Characterization of CD34+ Cells

By  

Journal of Stem Cells, Vol. , Iss. , 2017-07 ,pp. : 33-33

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Table 1. Details of the patients as per GMFCS, MACS and CMCS classifications

By  

Journal of Stem Cells, Vol. , Iss. , 2016-01 ,pp. : 46-46

Nova Science Publishers, Inc.

Access to resources Recommend Favorite